Literature DB >> 8249888

Use of cell image analysis in the detection of cancer from specimens obtained during endoscopic retrograde cholangiopancreatography.

P Yeaton1, R Kiss, J Deviere, I Salmon, N Bourgeois, J L Pasteels, M Cremer.   

Abstract

The authors report a scoring system based on cell image analysis of specimens obtained during endoscopic retrograde cholangiopancreatography from either the biliary or pancreatic duct epithelium. Nine normal, 20 inflammatory, and 19 malignant epithelia were assessed using a cell-image processor that permits determination of morphometric (nuclear area), densitometric (nuclear DNA content), and textural (chromatin distribution) parameters on Feulgen-stained nuclei. The score is based on three densitometric parameters: the DNA histogram type, the nuclear DNA content, and the percent proliferating cell population. These parameters permit distinction of normal and inflammatory from malignant epithelium with 95% sensitivity and 100% specificity. Cell-image analysis of specimens obtained during endoscopic retrograde cholangiopancreatography is a useful clinical tool in the detection of malignant lesions of the pancreas and biliary epithelia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8249888     DOI: 10.1093/ajcp/100.5.497

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  DNA flow cytometric analysis of paraffin-embedded tissue for the diagnosis of malignancy in bile duct biopsies.

Authors:  Hannah Lee; Peter S Rabinovitch; Aras N Mattis; Sanjay Kakar; Won-Tak Choi
Journal:  Hum Pathol       Date:  2020-04-06       Impact factor: 3.466

2.  Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures.

Authors:  Michael J Levy; Todd H Baron; Amy C Clayton; Felicity B Enders; Christopher J Gostout; Kevin C Halling; Benjamin R Kipp; Bret T Petersen; Lewis R Roberts; Ashwin Rumalla; Thomas J Sebo; Mark D Topazian; Maurits J Wiersema; Gregory J Gores
Journal:  Am J Gastroenterol       Date:  2008-05       Impact factor: 10.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.